JPMORGAN CHASE & CO - STOKE THERAPEUTICS INC ownership

STOKE THERAPEUTICS INC's ticker is and the CUSIP is 86150R907. A total of 3 filers reported holding STOKE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of STOKE THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$198,0008,3000.00%
Other shareholders
STOKE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 400$13,0000.00%
SIMPLEX TRADING, LLC 19$63,0000.00%
View complete list of STOKE THERAPEUTICS INC shareholders